CClinicalTrials.gg
RecruitingNCT06510205Updated Aug 28, 2026

The Study is an Observational Post-market Follow-up Program to Evaluate Long Term (5 Years) Safety of Mentor Breast Implants in Chinese Population

An observational study in Breast Augmentation and Mammaplasty, sponsored by Johnson & Johnson Medical (Shanghai) Ltd.. Recruiting at 4 sites in China. Open to female participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2026-08-28.

Sponsored by Johnson & Johnson Medical (Shanghai) Ltd. · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
6,111
Ages
18 Years to 100 Years
Sex
Female
01

Study summary

The Mentor Post-Market Clinical Follow-Up Study is a multicenter observational study conducted in China. It aims to collect safety data on Mentor breast implants over a 5-year follow-up period in the Chinese population. In addition to safety data, the study will also gather information on postoperative pain and participant satisfaction levels. The objective is to explore customers' clinical experiences and use them as a reference for future product development. The study intends to enroll different number of participants for each license.

02

Conditions studied

  • Breast Augmentation
  • Mammaplasty
03

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All populations receiving Mentor breast implants

Inclusion criteria

  1. Women who have received Mentor breast implants per product instructions;
  2. Participants must possess the ability to comprehend the study procedures, give consent for the use of their preoperative and surgical data, and agree to take part in postoperative follow-up assessments. Additionally, they should possess the necessary civil capacity, be capable of reading and writing, and willingly provide informed consent by signing the consent form.
  3. Aged not less than 18 years at the time of implantation surgery (for products with registration license Guoxie Zhujin 20223130323, the participant's age should be not less than 22 years).

Exclusion criteria

Exclusion Criteria:

  • Not applicable
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
6,111 participants (estimated)
Patient registry
No

Groups and cohorts

  • Mentor Group

    Who recieves Mentor breast implants per request

    Device: Mentor Breast implants

Interventions

  • DeviceMentor Breast implants

    Mentor breast implants are circular or waterdrop-shaped devices with shells made of successive cross-linked layers of silicone elastomer. The shell is filled with Mentor's proprietary formulation of silicone gel. Mentor breast implants are available in smooth and textured shells, both supplied in sterile form.

05

What researchers measure

Primary outcomes

  1. Breast implant related AEs

    Post-op 1 month, 3 months, 1 year, 2 years, 3 years, 4 years, 5 years

    Time frame: Up to 5 years

Secondary outcomes

  1. Numerical Pain Scale assessment

    Zero means you have no pain, while 10 represents the most intense pain possible.

    Time frame: 1 month after surgery

  2. Customer Satisfaction Score measurement

    Measured at 1 month, 3 months, 1 year, 2 years, 3 years, 4 years, 5 years after surgery Using a 5-point scoring scale, 5 means very satisfied while 1 means very disatisfied.

    Time frame: Up to 5 years after surgery

06

Study locations

4 of 4 sites recruiting
  • Sichuan Huamei Zixin Medical Aesthetic Hospital
    Chengdu, 610000, China
    Recruiting
  • Yunnan Huamei Meilai Cosmetology Hospital
    Kunming, 650000, China
    Recruiting
  • Shenzhen Yixing Medical Cosmetology Hospital
    Shenzhen, 518000, China
    Recruiting
  • Shenzhen Junke Medical Cosmetology Clinic
    Shenzhen, 519000, China
    Recruiting
07

References and documents

Individual participant data

Plan to share: Yes — The data sharing policy of Johnson \& Johnson MedTech is available at innovativemedicine.jnj.com/our-innovation/clinical-trials/transparency. As noted on this site, requests for access to the study data can be submitted through Yale Open Data Access (YODA) Project site at yoda.yale.edu

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT06510205
Lead sponsor
Johnson & Johnson Medical (Shanghai) Ltd.
Responsible party
Sponsor
First posted
Jul 19, 2024
Start date
Jul 14, 2024
Primary completion
Jun 30, 2034 (estimated)
Completion
Dec 31, 2034 (estimated)
Last update
Aug 28, 2026

Study contacts

Study Contact
Contact
ygu51@its.jnj.com
+86 15692105615
Huimin Wu
study director · Shenzhen Junke Medical Cosmetology Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion